Google Übersetzer
Sino Biological Inc. Class A
About
66.80CNY-0.10 -0.15%
Closed • Updated at 20:24 GMT+00:00Market Cap$1.20B
P/E Ratio51.67
Volume847.3K
Beta1.04
RSI31.55
Gross Margin78.03%
Sino Biological Inc. Class A — investor relations, events, news, and company updates on 6ix.
Latest News
May 19 2026
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
May 18 2026
Sino Biological Launches XPressMAX(TM) Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
Mar 4 2026
Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
Jan 28 2026
Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development
Jul 14 2025
Sino Biological Sets New Industry Standard With ProPure(TM) Endotoxin-Free Proteins Made in the USA